title: Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis.
authors.forename: I
authors.initials: I
authors.lastname: Olivieri
authors.forename: Salvatore
authors.initials: S
authors.lastname: D'Angelo
authors.forename: C
authors.initials: C
authors.lastname: Palazzi
authors.forename: P
authors.initials: P
authors.lastname: Leccese
authors.forename: A
authors.initials: A
authors.lastname: Nigro
authors.forename: A
authors.initials: A
authors.lastname: Padula
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D004311:Double-Blind Method; D006801:Humans; D000069285:Infliximab; D015337:Multicenter Studies as Topic; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D025241:Spondylarthritis / Q000145:classification / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab